Telomir Pharmaceuticals, Inc. TELO
1.23
0.02
1.65%
as of 25 Sep
- Market cap
- $83.2M
- P/E
- 0.0×
Follow TELO
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | |
|---|---|---|---|---|
Current Ratio |
5.14 | 1.94 | 0.33 | 0.05 |
Net Debt/EBITDA |
0.69 | 0.16 | (0.04) | 0.00 |
Debt/Assets |
0.00% | 0.00% | 2.12% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.03 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.35 | 0.31 | 0.30 | 0.55 |
Capex/Depreciation |
— | 0.00 | 0.00 | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 |
| (317.65%) | (810.19%) | (1,045.38%) | 0.00% | |
| (240.34%) | (542.25%) | (542.12%) | 0.00% | |
ROIC |
0.00% | 0.00% | (69.64%) | 0.00% |
Return on Tangible Assets |
(176.09%) | (2,571.18%) | 1,451.79% | 91.12% |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | — | — |
Free Cash Flow per Share |
(0.12) | (0.17) | (0.14) | (0.02) |
Cash per Share |
0.23 | 0.04 | 0.00 | 0.00 |
Shareholders Equity per Share |
0.19 | 0.02 | 0.13 | (0.03) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.19 | 0.02 | 0.13 | (0.03) |
Free Cash Flow |
(3.69) | (5.07) | (3.86) | (0.47) |
Working Capital |
5.91 | 0.64 | (0.90) | (0.94) |
Net Current Asset Value |
5.91 | 0.64 | (0.90) | (0.94) |
| Other line items | ||||
Quick Ratio |
5.10 | 1.86 | 0.00 | 0.00 |
Depreciation/Fixed assets |
— | 0.00 | 0.00 | — |
Cash ROIC |
(27.94%) | (265.59%) | (109.02%) | 50.08% |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.12) | (0.17) | (0.14) | (0.02) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
0.56 | 0.65 | 0.56 | — |
Average Assets |
4.33 | 3.05 | 2.41 | — |
Average Common Equity |
3.28 | 2.04 | 1.25 | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates